T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Schneider National
SNDR
$6.37B
| $253K | ﹤0.01% |
9,126
+748
| +9% | +$21.8K |
|
2402
Fulgent Genetics
FLGT
$513M
| $251K | ﹤0.01% |
9,355
+351
| +4% | +$12K |
|
2403
Lemonade
LMND
$4.1B
| $251K | ﹤0.01% |
21,517
-623
| -3% | -$9.99K |
|
2404
Northrim BanCorp
NRIM
$601M
| $251K | ﹤0.01% |
+25,340
| New | +$272K |
|
2405
Trupanion
TRUP
$1.36B
| $251K | ﹤0.01% |
+8,875
| New | +$252K |
|
|
TAST
2406
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $251K | ﹤0.01% |
38,041
-29,323
| -44% | -$180K |
|
2407
Crescent Energy
CRGY
$3.93B
| $250K | ﹤0.01% |
19,707
+430
| +2% | +$5.26K |
|
|
ORC
2408
Orchid Island Capital
ORC
$1.32B
| $250K | ﹤0.01% |
29,298
-1,319
| -4% | -$12.9K |
|
2409
iHeartMedia
IHRT
$464M
| $249K | ﹤0.01% |
78,770
+7,482
| +10% | +$28.2K |
|
2410
Vipshop
VIPS
$6.8B
| $249K | ﹤0.01% |
15,490
+160
| +1% | +$2.6K |
|
|
TSE
2411
DELISTED
Trinseo
TSE
| $248K | ﹤0.01% |
30,328
+10,684
| +54% | +$135K |
|
|
CDMO
2412
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $247K | ﹤0.01% |
26,115
+1,367
| +6% | +$16.5K |
|
2413
Lifestance Health
LFST
$4.67B
| $246K | ﹤0.01% |
35,752
+2,455
| +7% | +$19.9K |
|
2414
Bally's
BALY
$660M
| $244K | ﹤0.01% |
18,556
+981
| +6% | +$15K |
|
|
PNT
2415
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $244K | ﹤0.01% |
36,531
+9,558
| +35% | +$79.4K |
|
2416
LivePerson
LPSN
$35.9M
| $243K | ﹤0.01% |
4,158
+124
| +3% | +$8.16K |
|
2417
Royal Bank of Canada
RY
$299B
| $243K | ﹤0.01% |
2,770
| – | – |
|
2418
Upland Software
UPLD
$17.9M
| $243K | ﹤0.01% |
5,247
| – | – |
|
|
VERV
2419
DELISTED
Verve Therapeutics
VERV
| $243K | ﹤0.01% |
18,320
+1,447
| +9% | +$23.3K |
|
2420
LeMaitre Vascular
LMAT
$1.87B
| $242K | ﹤0.01% |
4,431
+469
| +12% | +$27.8K |
|
2421
PubMatic
PUBM
$787M
| $242K | ﹤0.01% |
19,942
+963
| +5% | +$14.7K |
|
2422
Winmark
WINA
$1.26B
| $242K | ﹤0.01% |
+646
| New | +$234K |
|
2423
Employers Holdings
EIG
$871M
| $241K | ﹤0.01% |
6,031
+462
| +8% | +$17.9K |
|
|
EQRX
2424
DELISTED
EQRx, Inc. Common Stock
EQRX
| $241K | ﹤0.01% |
108,286
-41,179
| -28% | -$88.2K |
|
2425
Dutch Bros
BROS
$8.93B
| $240K | ﹤0.01% |
10,300
+3,300
| +47% | +$94K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.